Leerink Partners Remains Sidelined on Agios Pharma (AGIO) - PT to $56
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on tech boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil prices rise on Trump timeline for Iran peace deal: after US elections
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Agios Pharma (AGIO) Reports Q4 Loss of $1.08/Share
February 18, 2016 7:15 AM ESTAgios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.08), versus ($0.76) reported last year. Revenue for the quarter came in at $6.22 million, versus $14.64 million reported last year.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... MoreTrading Radar for 2/18: Wal-mart (WMT), Cabela's (CAB), Nordstrom (JWN), Leidos (LDOS), SodaStream (SODA) Report
February 17, 2016 3:18 PM EST(Updated - February 17, 2016 3:19 PM EST)
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
ALLETE, Inc. (NYSE: ALE) - consensus EPS $0.78
Aaron's (NYSE: AAN) - consensus EPS $0.38
Agios Pharma (Nasdaq: AGIO) - consensus loss $0.50
Atlas Air Worldwide... More

